Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Borský

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Ceskoslovenska Dermatologie|March 1, 1977
[Melanosis Becker (author's transl)]R Schwank, M Borský, F Vosmík
Ceskoslovenska Dermatologie|August 1, 1981
[Microsporosis familiaris (author's transl)]J Kejda, M Borský, J Spousta
Casopis Lekaru Ceskych|December 22, 1999
[Direct DNA diagnosis of Friedreich's ataxia]M Borský, V Pekarík, M Tvrdíková, et al.
Ceskoslovenska Stomatologie|January 1, 1976
[Relationship between dental and bone maturation]P Bleha, J Havlík, M Borský, et al.
Neoplasma|June 11, 2004
Telomerase as a diagnostic and predictive marker in colorectal carcinomaJ Maláska, Z Kunická, M Borský, et al.
International Journal of Laboratory Hematology|September 14, 2013
Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practiceO Stehlíková, J Chovancová, B Tichý, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 19, 2026
Polyclonal hypergammaglobulinemia, infiltration of the salivary glands, lymphadenopathy, and kidney damage - Mikulicz's disease, Sjögren's syndrome, or Castleman's disease? Case report and overview of differential diagnosis and treatmentZ Adam, Z Fojtík, Z Řehák, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|November 8, 2024
Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone, followed by rituximab and dexamethasone maintenance, achieved disappearance of pathological PET accumulation of FDG and regression of fibrotic masses after 4 months…A Čermák, J Foukal, Z Řehák, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 17, 2025
Description of TEMPI syndrome in Waldenström's macroglobulinemiaZ Adam, L N Leová, M Patočková, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|October 30, 2025
Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitorsM Štork, J Kotašková, E Ondroušková, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Ceskoslovenska Dermatologie|March 1, 1977
[Melanosis Becker (author's transl)]R Schwank, M Borský, F Vosmík
Ceskoslovenska Dermatologie|August 1, 1981
[Microsporosis familiaris (author's transl)]J Kejda, M Borský, J Spousta
Casopis Lekaru Ceskych|December 22, 1999
[Direct DNA diagnosis of Friedreich's ataxia]M Borský, V Pekarík, M Tvrdíková, et al.
Ceskoslovenska Stomatologie|January 1, 1976
[Relationship between dental and bone maturation]P Bleha, J Havlík, M Borský, et al.
Neoplasma|June 11, 2004
Telomerase as a diagnostic and predictive marker in colorectal carcinomaJ Maláska, Z Kunická, M Borský, et al.
International Journal of Laboratory Hematology|September 14, 2013
Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practiceO Stehlíková, J Chovancová, B Tichý, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 19, 2026
Polyclonal hypergammaglobulinemia, infiltration of the salivary glands, lymphadenopathy, and kidney damage - Mikulicz's disease, Sjögren's syndrome, or Castleman's disease? Case report and overview of differential diagnosis and treatmentZ Adam, Z Fojtík, Z Řehák, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|November 8, 2024
Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone, followed by rituximab and dexamethasone maintenance, achieved disappearance of pathological PET accumulation of FDG and regression of fibrotic masses after 4 months…A Čermák, J Foukal, Z Řehák, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 17, 2025
Description of TEMPI syndrome in Waldenström's macroglobulinemiaZ Adam, L N Leová, M Patočková, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|October 30, 2025
Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitorsM Štork, J Kotašková, E Ondroušková, et al.
Pageof 1